+919405117673
Cyclophosphamide 200mg / 500mg / 1000mg Injection – Global Oncology Medicine Exporter from India
Cordium Pharmaceuticals Pvt Ltd is a trusted global supplier and exporter of Cyclophosphamide 200mg, 500mg, and 1000mg injections, delivering high-quality oncology medicines to hospitals, cancer clinics, pharmacies, distributors, and personal import buyers worldwide. With reliable international logistics and affordable pharmaceutical export solutions, the company supplies anti-cancer injections to the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.

What is Cyclophosphamide Injection?

Cyclophosphamide is a widely used chemotherapy and immunosuppressive medicine classified as an alkylating agent. It works by slowing or stopping the growth of cancer cells and is commonly prescribed in modern oncology treatment protocols. Cyclophosphamide injections are used in the treatment of multiple cancers, including breast cancer, lymphoma, leukemia, ovarian cancer, lung cancer, and multiple myeloma.

Available Strengths for Global Export

Cordium Pharmaceuticals Pvt Ltd supplies:

Cyclophosphamide 200mg Injection
Cyclophosphamide 500mg Injection
Cyclophosphamide 1000mg Injection

These oncology injectable medicines are manufactured and packed under strict pharmaceutical quality standards for international export supply.



Cyclophosphamide injections are commonly prescribed for:

Breast Cancer Treatment
Leukemia Management
Hodgkin and Non-Hodgkin Lymphoma
Ovarian Cancer Therapy
Multiple Myeloma Treatment
Lung Cancer Chemotherapy
Autoimmune Disorders
Nephrotic Syndrome
Bone Marrow Transplant Conditioning

The medicine is administered intravenously under the supervision of qualified healthcare professionals and dosage depends on patient condition, body weight, and oncology treatment protocols.

Benefits of Choosing Cordium Pharmaceuticals Pvt Ltd
Trusted Pharmaceutical Exporter from India

Cordium Pharmaceuticals Pvt Ltd is recognized for supplying premium-quality oncology medicines globally with reliable export support.

Worldwide Delivery Network

The company exports oncology medicines to healthcare providers and import buyers in the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.

Supply for Multiple Buyer Categories

Cordium Pharmaceuticals caters to:

Hospitals
Oncology Clinics
Cancer Treatment Centers
Pharmacies
Pharmaceutical Distributors
Government Tenders
Personal Import Buyers
Fast and Secure International Shipping

The company offers professional export packaging, temperature-sensitive handling support, and fast global delivery for urgent oncology requirements.

Important Safety Information

Cyclophosphamide injections must only be administered by qualified medical professionals. Common side effects may include nausea, vomiting, fatigue, hair loss, low blood cell counts, and risk of infections. Regular monitoring of liver function, kidney function, and blood counts is recommended during treatment.

Patients should avoid self-medication and follow oncologist guidance strictly during chemotherapy treatment.

Why Global Buyers Prefer Indian Oncology Medicine Exporters

India has become a leading hub for affordable oncology medicines and pharmaceutical exports due to:

Competitive pricing
WHO-GMP manufacturing facilities
High-quality generic oncology products
Reliable export logistics
Growing global pharmaceutical compliance

Cordium Pharmaceuticals Pvt Ltd continues to support healthcare providers and importers with affordable cancer treatment medicine exports and dependable supply chain management.

Order Cyclophosphamide Injection Worldwide

For bulk supply, hospital procurement, distributor partnerships, pharmacy orders, or personal import enquiries, contact:

WhatsApp: +91-9405117673
Email: info@cordiumpharma.com

Official Website: Cordium Pharmaceuticals Pvt Ltd Official Website

Worldwide export support available for the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
May 21st, 2026 11:37 AM

Keywords